Seasonal increases in peripheral innatelymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

MOSBY-ELSEVIER

1. NIAID NIH HHS [N01 AI15416] Funding Source: Medline
2. Wellcome Trust [097881/Z/11/Z] Funding Source: Medline
3. Wellcome Trust [097881/Z/11/Z] Funding Source: Wellcome Trust